WBCIL at IPHEX 2026 India: Liposomal APIs and Pharmaceutical Ingredients at Stall 2C-09
Liposomal Technology at IPHEX 2026: The Lipoedge™ API Range
Conventional mineral salts have never fully solved oral bioavailability. Ferrous sulphate is incompletely absorbed and causes significant GI side effects. Standard calcium forms depend on gastric acid for dissolution. Fat-soluble vitamins like D3, K2, and CoQ10 require dietary fat for absorption. Liposomal encapsulation addresses these limitations structurally. The active ingredient is housed within a phospholipid bilayer vesicle. The intestinal epithelium recognises and transports this structure directly. Absorption bypasses the solubility and transporter limitations of free molecules. For iron specifically, liposomal delivery substantially reduces GI side effects. This improves patient compliance, a documented problem with conventional iron supplementation. We produce every Lipoedge™ product at our WHO-GMP-certified facilities. Manufacturing sites are located in Kolkata and Dahej, Gujarat. Particle size distribution is controlled. PDI specifications are validated. Complete technical dossiers are available for regulatory submissions globally.
Lipoedge™ Liposomal API Portfolio at IPHEX 2026:
- Lipoedge™ Liposomal Iron (patented)
- Lipoedge™ Liposomal Magnesium
- Lipoedge™ Liposomal Zinc
- Lipoedge™ Liposomal Glutathione
- Lipoedge™ Liposomal Vitamin C
- Lipoedge™ Liposomal Calcium
- Lipoedge™ Liposomal Alpha Lipoic Acid (ALA)
- Lipoedge™ Liposomal Vitamin D3
- Lipoedge™ Liposomal CoQ10
- Lipoedge™ Liposomal Vitamin K2
Liposomal Iron and Liposomal Magnesium are our highest-demand products among Indian formulators. Liposomal Zinc and Liposomal Glutathione serve the immunity and antioxidant segment. Liposomal Calcium complements our conventional calcium range for premium bone health formulations.
Conventional Pharmaceutical Ingredients: Iron APIs, Chelated Minerals & Speciality Molecules
Iron APIs
Iron deficiency anaemia is India’s highest-volume therapeutic category. Selecting the right iron compound directly affects bioavailability, tolerability, and patient compliance. WBCIL manufactures across the full spectrum of pharmaceutical-grade iron molecules.
- Ferric Ammonium Citrate: widely used in liquid iron formulations; high iron content with good palatability
- Ferrous Bisglycinate: amino acid chelate; superior GI tolerability profile compared to inorganic iron salts
- Iron III Hydroxide Polymaltose Complex (IPC): non-ionic, stable polymaltose complex; established safety profile with extensive clinical literature
- Ferrous Ascorbate: combination of ferrous iron and Vitamin C in a single molecule; enhances iron absorption through ascorbic acid co-presentation
Chelated Minerals
Magnesium Bisglycinate: A glycinate chelate with high elemental magnesium content. It demonstrates strong GI tolerability relative to oxide and citrate forms. It is increasingly specified in stress, sleep, and metabolic health formulations.
DC-Grade Calcium
Calcium Citrate DC: Calcium Citrate DC is formulated for direct compression tabletting. It eliminates wet granulation, reducing manufacturing time and process cost. Compressibility and flow properties are validated for consistent tablet production.
Specialty Folate
L-Methylfolate (L-5-MTHF): L-Methylfolate is the biologically active form of folate. It bypasses the MTHFR enzyme conversion pathway entirely. This makes it clinically relevant for patients with MTHFR gene polymorphisms. Synthetic folic acid cannot perform this function in affected individuals. L-Methylfolate is increasingly specified in prenatal, women’s health, and neurological support formulations.
Why Meet WBCIL at IPHEX India 2026?
WBCIL is a WHO-GMP-certified pharmaceutical ingredient manufacturer with supply relationships across more than 40 countries. Our documentation infrastructure meets ICH Q7, WHO-GMP, and international filing requirements. We maintain stability data, DMFs, and technical dossiers across all core product lines. CDSCO compliance requirements have tightened considerably in recent years. Export-facing manufacturers now need documentation that satisfies domestic and international standards simultaneously. Premium nutraceutical brands need supplier-backed bioavailability data — not marketing claims. WBCIL provides both. At Stall 2C-09, our team is equipped for precise technical and commercial conversations.
What You Can Discuss at Stall 2C-09
- Technical specifications and stability data for any listed product
- DMF availability and regulatory filing support for target markets
- Particle size and PDI customisation for liposomal APIs
- Pricing, MOQ, and supply chain structure for India and export
- Formulation guidance for tablets, sachets, liquids, and capsules
IPHEX India 2026 brings India’s pharmaceutical formulations decision-makers into one venue. Procurement leads, R&D teams, and product developers will all be present. This platform is designed for technical conversations that move forward. Bring your sourcing brief or formulation specification to Stall H2/C09. Our team will be ready with samples, datasheets, and direct technical support.
Visit us at Stall H2/C09.
To schedule a meeting in advance or request technical documentation before IPHEX 2026, write to us at wbcil@wbcil.com
